glp-1 agonist or antagonist Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Video: Non-insulin injectable antidiabetic drugs

However, it's important to note that many of these studies are observational and do not prove that GLP-1 medications cause the reduced risk

consider gentle laxatives if needed Will it get better

Trial data have shown decreases in serious cardiovascular complications, including cardiovascular mortality, nonlethal heart attacks, and nonfatal cerebrovascular accidents, among individuals with type 2 diabetes and pre-existing cardiovascular pathology or high cardiovascular risk [3,5,13,14,37]

The beneficial actions based on activation of the entero-insular axis are complex and multitargeted, involving the gut, brain, pancreas, and liver

K.GangopadhyayK

Add the mushrooms, kale and chicken to a bowl and top with sliced avocado